Background The European AIDS Clinical Society (EACS) Guidelines were revised in 2021 for the 17th time with updates on all aspects of HIV care. Key points of the Guidelines update Version 11.0 of the Guidelines recommend six first-line treatment options for antiretroviral treatment (ART)-naive adults: tenofovir-based backbone plus an unboosted integrase inhibitor or plus doravirine; abacavir/lamivudine plus dolutegravir; or dual therapy with lamivudine or emtricitabine plus dolutegravir. Recommendations on preferred and alternative first-line combinations from birth to adolescence were included in the new paediatric section made with Penta. Long-acting cabotegravir plus rilpivirine was included as a switch option and, along with fostemsavir, was added to all drug-drug interaction (DDI) tables. Four new DDI tables for anti-tuberculosis drugs, anxiolytics, hormone replacement therapy and COVID-19 therapies were introduced, as well as guidance on screening and management of anxiety disorders, transgender health, sexual health for women and menopause. The sections on frailty, obesity and cancer were expanded, and recommendations for the management of people with diabetes and cardiovascular disease risk were revised extensively. Treatment of recently acquired hepatitis C is recommended with ongoing risk behaviour to reduce transmission. Bulevirtide was included as a treatment option for the hepatitis Delta virus. Drug-resistant tuberculosis guidance was adjusted in accordance with the 2020 World Health Organization recommendations. Finally, there is new guidance on COVID-19 management with a focus on continuance of HIV care. Conclusions In 2021, the EACS Guidelines were updated extensively and broadened to include new sections. The recommendations are available as a free app, in interactive web format and as an online pdf.

Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021 / Ryom, Lene; De Miguel, Rosa; Cotter, Aoife Grace; Podlekareva, Daria; Beguelin, Charles; Waalewijn, Hylke; Arribas, Josè R; Mallon, Patrick W G; Marzolini, Catia; Kirk, Ole; Bamford, Alasdair; Rauch, Andri; Molina, Jean Michel; Kowalska, Justyna Dominika; Guaraldi, Giovanni; Winston, Alan; Boesecke, Christoph; Cinque, Paola; Welch, Steven; Collins, Simon; Behrens, Georg M N. - In: HIV MEDICINE. - ISSN 1464-2662. - 23:8(2022), pp. 849-858. [10.1111/hiv.13268]

Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021

Guaraldi, Giovanni;
2022

Abstract

Background The European AIDS Clinical Society (EACS) Guidelines were revised in 2021 for the 17th time with updates on all aspects of HIV care. Key points of the Guidelines update Version 11.0 of the Guidelines recommend six first-line treatment options for antiretroviral treatment (ART)-naive adults: tenofovir-based backbone plus an unboosted integrase inhibitor or plus doravirine; abacavir/lamivudine plus dolutegravir; or dual therapy with lamivudine or emtricitabine plus dolutegravir. Recommendations on preferred and alternative first-line combinations from birth to adolescence were included in the new paediatric section made with Penta. Long-acting cabotegravir plus rilpivirine was included as a switch option and, along with fostemsavir, was added to all drug-drug interaction (DDI) tables. Four new DDI tables for anti-tuberculosis drugs, anxiolytics, hormone replacement therapy and COVID-19 therapies were introduced, as well as guidance on screening and management of anxiety disorders, transgender health, sexual health for women and menopause. The sections on frailty, obesity and cancer were expanded, and recommendations for the management of people with diabetes and cardiovascular disease risk were revised extensively. Treatment of recently acquired hepatitis C is recommended with ongoing risk behaviour to reduce transmission. Bulevirtide was included as a treatment option for the hepatitis Delta virus. Drug-resistant tuberculosis guidance was adjusted in accordance with the 2020 World Health Organization recommendations. Finally, there is new guidance on COVID-19 management with a focus on continuance of HIV care. Conclusions In 2021, the EACS Guidelines were updated extensively and broadened to include new sections. The recommendations are available as a free app, in interactive web format and as an online pdf.
2022
23
8
849
858
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021 / Ryom, Lene; De Miguel, Rosa; Cotter, Aoife Grace; Podlekareva, Daria; Beguelin, Charles; Waalewijn, Hylke; Arribas, Josè R; Mallon, Patrick W G; Marzolini, Catia; Kirk, Ole; Bamford, Alasdair; Rauch, Andri; Molina, Jean Michel; Kowalska, Justyna Dominika; Guaraldi, Giovanni; Winston, Alan; Boesecke, Christoph; Cinque, Paola; Welch, Steven; Collins, Simon; Behrens, Georg M N. - In: HIV MEDICINE. - ISSN 1464-2662. - 23:8(2022), pp. 849-858. [10.1111/hiv.13268]
Ryom, Lene; De Miguel, Rosa; Cotter, Aoife Grace; Podlekareva, Daria; Beguelin, Charles; Waalewijn, Hylke; Arribas, Josè R; Mallon, Patrick W G; Marzo...espandi
File in questo prodotto:
File Dimensione Formato  
MajorRevision.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 159.62 kB
Formato Adobe PDF
159.62 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1277102
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 61
  • ???jsp.display-item.citation.isi??? 56
social impact